Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-10, Stock:JNJ, The news for the past five days is as follows:
2021-11-03: NEWS1: U.S. administers 425.3 mln doses of COVID-19 vaccines - CDC.NEWS2: COVID-19 vaccine has ‘an incredibly positive benefit to risk ratio’: Doctor.NEWS3: 10 Best Cancer Stocks To Buy Now.NEWS4: UPDATE 1-Italy recommends Pfizer or Moderna booster for those who had J&J shot.NEWS5: CDC recommends Pfizer COVID-19 vaccine for kids ages 5 to 11.NEWS6: Here's What Investors Need to Know About Johnson & Johnson's Q3 Earnings.NEWS7: Johnson & Johnson Launches a Health Equity Innovation Challenge in 6 U.S. Cities.NEWS8: Halozyme (HALO) Beats on Q3 Earnings, Tweaks 2021 Guidance.NEWS9: Italy recommends Pfizer or Moderna booster for those who had J&J shot.NEWS10: 11 Best Income Stocks To Buy Right Now.NEWS11: Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?.NEWS12: Covid Vaccines for Children Are Here. What to Know..
2021-11-04: NEWS1: Emergent BioSolutions, feds terminate long-running pandemic preparedness contract.NEWS2: RTP firm to coordinate study on Covid vaccines, autoimmune disease.NEWS3: 7 Stocks to Buy to Hone in on Ray Dalio’s Reliable Favorites.NEWS4: 7 Safe Stocks that are Immune from China’s Market Volatility.NEWS5: Theravance's (TBPH) Q3 Earnings Beat, Restructuring On Track.NEWS6: 10 Stocks To Buy Now According To Stamos Capital.
2021-11-05: NEWS1: J&J Renews Fight to Halt Baby Powder Suits Using Bankruptcy.NEWS2: Epidemiologist slams Aaron Rogers comments on COVID-19: 'It actually is a pandemic of the unvaccinated'.NEWS3: U.S. authorizes more batches of J&J COVID-19 vaccine made at Emergent.NEWS4: See Why Emergent BioSolutions Stock Plunged 37% On Friday?.NEWS5: 10 Dividend Stocks With Over 10% Yield.NEWS6: Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock.NEWS7: FATE's Q3 Loss Narrower Than Expected, Pipeline in Focus.NEWS8: Emergent Tanks as U.S. Ends Contract, Vaccine Maker Cuts Outlook.NEWS9: Emergent Biosolutions shares tumble on news it will lose COVID vaccine production contract with govt'.NEWS10: Emergent BioSolutions Stock Plunges After Key Government Contract Terminated.NEWS11: Coronavirus tally: Global cases of COVID-19 top 248.7 million and U.S. cancels Emergent BioSolutions vaccine deal.NEWS12: The Novavax Rebound Is Just Warming Up.NEWS13: U.S. cancels multimillion dollar deal with Emergent BioSolutions, which produced contaminated J&J vaccines: report.NEWS14: 10 Stocks to Buy Under $15 According to Canadian Billionaire Prem Watsa.NEWS15: J&J fails in final bid to appeal Australian pelvic mesh class action ruling.NEWS16: J&J fails in final bid to appeal Australian pelvic mesh class action ruling.
2021-11-08: NEWS1: U.S. administers 432 mln COVID-19 vaccine doses, 70% adults fully vaccinated- CDC.NEWS2: IBD/TIPP Poll: Vaccine Holdouts Dig In With Pfizer, Merck Antiviral Pills Looming.NEWS3: Travel 'confidence level' is surging amid COVID-19 vaccinations: Vacasa CEO.NEWS4: Coronavirus: Infectious diseases physician details the latest news and therapeutics in pandemic.NEWS5: 10 Dividend ETFs to Buy Now.NEWS6: Immunovant (IMVT) Reports Wider-Than-Expected Loss in Q2.NEWS7: COVID testing costs, hospitalization to drop as treatments enter market: Analyst.NEWS8: 2 Leading Healthcare Stocks to Buy in 2021 and Beyond.
2021-11-09: NEWS1: Oklahoma court overturns $465 million opioid ruling against Johnson & Johnson.NEWS2: Johnson & Johnson Opioid Verdict Overturned by Oklahoma Supreme Court.NEWS3: Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards.NEWS4: U.S. administers 433.2 mln doses of COVID-19 vaccines - CDC.NEWS5: Janssen Partially Terminates Nanoparticle License Agreement With Alkermes.NEWS6: UPDATE 4-Oklahoma court overturns $465 mln opioid judgment against J&J.NEWS7: Oklahoma court overturns $465 million opioid judgment against J&J.NEWS8: Oklahoma court overturns $465 million opioid award against Johnson & Johnson.NEWS9: Why Alkermes Stock Is Sinking Today.NEWS10: Wave of Solid Q3 Earnings Push Pharma ETFs Higher.NEWS11: Oklahoma Court Overturns Opioid Judgement Against J&J.NEWS12: The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data.NEWS13: Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?.

Answer: Rise